Patient Leaflet Updated 06-Aug-2026 | Lundbeck Limited
Clopixol Acuphase Injection
Clopixol-Acuphase® 50 mg/ml solution for injection
zuclopenthixol acetate
1. What Clopixol-Acuphase is and what it is used for
2. What you need to know before you are given Clopixol-Acuphase
3. How Clopixol-Acuphase is given
4. Possible side effects
5. How to store Clopixol-Acuphase
6. Contents of the pack and other information
The name of your medicine is Clopixol-Acuphase 50 mg/ml solution for injection (called Clopixol-Acuphase in this leaflet). Clopixol-Acuphase contains the active substance zuclopenthixol. Clopixol-Acuphase belongs to a group of medicines known as antipsychotics (also called neuroleptics). These medicines act on nerve pathways in specific areas of the brain and help to correct certain chemical imbalances in the brain that are causing the symptoms of your illness.
Clopixol-Acuphase is used for the initial treatment of short-term psychoses including mania or increases in the severity of existing psychoses.
Talk to your doctor, pharmacist or nurse before Clopixol-Acuphase is given to you:
Movement disorders such as tremors and muscle spasm may occur, especially during the first few days after initiating therapy. Inform your doctor as the dose may need to be reduced. Inform your doctor if symptoms of a constant urge to move are persistent, as these symptoms can be controlled by the appropriate medication. Inform your doctor if you experience uncontrolled movements of the face and jaw, as therapy discontinuation may be needed.
Difficulty in swallowing may occur as a secondary effect of extrapyramidal symptoms (such as tremors, muscle spasm or movement disorder), sedation (sleepiness), increased salivation, and/or neuroleptic malignant syndrome (a rare dangerous reaction with fever, rigid muscles, changing blood pressure and coma).
Clopixol-Acuphase is not recommended in this patient group.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
The following medicines should not be taken at the same time as Clopixol-Acuphase:
Tell your doctor or pharmacist if you are taking any of the following medicines
Clopixol-Acuphase can reduce the effect of adrenaline (epinephrine) and similar drugs.
Tell your doctor, dentist, surgeon or anaesthetist before any operation as Clopixol-Acuphase can increase the effects of general anaesthetics, muscle relaxing drugs and drugs used to prevent clots.
Clopixol-Acuphase may increase the sedative effects of alcohol making you drowsier. It is recommended not to drink alcohol during treatment with Clopixol-Acuphase.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
If you are pregnant or think you might be pregnant, tell your doctor. Clopixol-Acuphase should not be used during pregnancy unless clearly necessary.
The following symptoms may occur in newborn babies, of mothers that have used Clopixol-Acuphase in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/ or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these symptoms you may need to contact your doctor.
Breast-feeding
If you are breast-feeding, ask your doctor for advice. Clopixol-Acuphase should not be used when breast-feeding, as small amounts of the medicine can pass into the breast milk.
Fertility
Zuclopenthixol may decrease your sexual activity and fertility. These are not lasting effects. Please talk to your doctor about any problems.
There is a risk of feeling drowsy or dizzy, or suffering from blurred vision when being treated with Clopixol-Acuphase, especially at the start of your treatment. If this happens do not drive or use any tools or machines.
A small amount of Clopixol-Acuphase is drawn up into a syringe and then injected into the muscle of your buttock or thigh.
Your doctor will decide on the correct amount of medicine to give.
The usual dose lies between 50-150 mg (1-3 ml) repeated if necessary after 2-3 days.
Some patients may require an additional dose 1 or 2 days after the first injection.
Treatment can continue for up to 2 weeks. In this time you may receive a total of 4 injections up to a total dose of 400 mg (8 ml).
If further treatment is necessary, your doctor will prescribe suitable medication immediately or shortly after the Clopixol-Acuphase injections are stopped.
Older patients may need smaller doses. The maximum dose per injection is 100 mg.
If you have renal failure, your dosage should be reduced to half the usual dosage range. If you have liver problems, the level of zuclopenthixol in your blood may be checked. Patients with liver complaints normally receive doses at half the usual dosage range.
Clopixol-Acuphase is not recommended for children.
Treatment with Clopixol-Acuphase can continue for up to 2 weeks. After this time if treatment is still needed it can be continued with Clopixol tablets, Clopixol injection or Clopixol Conc. injection.
If you feel that the effect of Clopixol-Acuphase is too strong or weak, talk to your doctor or pharmacist.
Your medicine will be given by your doctor/nurse.
In the unlikely event that you receive too much Clopixol-Acuphase you may experience some symptoms.
Symptoms of overdose may include:
You will receive treatment for any of these symptoms from your doctor or nurse.
Like all medicines, Clopixol-Acuphase can cause side effects, although not everybody gets them.
Stop using Clopixol and seek medical advice immediately if you have any of the following allergic reactions:
Blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you notice any of these symptoms seek medical advice immediately.
If you get any of the following symptoms you should contact your doctor immediately as your dose may need to be reduced or stopped:
Common (may affect more than 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may occur in up to 1 out of 1000 people):
Very rare (may affect up to 1 in 10,000 people):
Side effects are most pronounced the day after the first treatment and usually wear off soon afterwards.
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
As with other medicines that work in a way similar to zuclopenthixol (the active ingredient of Clopixol), rare cases of the following side effects have been reported:
In rare cases irregular heart beats (arrhythmias) may have resulted in sudden death.
In older people with dementia, a small increase in the number of deaths has been reported for patients taking antipsychotics compared with those not receiving antipsychotics.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below)
By reporting side effects you can help provide more information on the safety of this medicine.
United Kingdom
or search for MHRA Yellow Card in the Google Play or Apple App Store.
Your doctor or nurse will store the medicine for you. If you keep it at home:
This medicinal product does not require any special temperature storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is zuclopenthixol acetate.
Each millilitre (ml) of Clopixol-Acuphase contains 50 mg zuclopenthixol acetate.
The other ingredient is thin vegetable oil (purified from coconut oil).
Clopixol-Acuphase is an oily liquid.
Clopixol-Acuphase is available in glass ampoules containing 1 ml (50 mg) in cartons of 5 ampoules.
This leaflet was last revised in 04/2026.
To request a copy of this leaflet in braille, large print or audio please call free of charge:
0800 198 5000
Please be ready to give the following information:
Product name Product code number
Clopixol-Acuphase PL 00458/0063
This is a service provided by the Royal National Institute of Blind People.
Iveco House, Station Road, Watford, Hertfordshire, WD17 1ET, UK
http://www.lundbeck.co.uk
+44 (0)1908 649 966
+44 (0)1908 649966
+44 (0)1908 638 972